Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms
The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …
COVID-19 and myositis: what we know so far
Purpose Myositis as a rare manifestation of COVID-19 is only recently being reported. This
review examines the current literature on COVID-19-induced myositis focusing on …
review examines the current literature on COVID-19-induced myositis focusing on …
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …
vaccines. Our prospective observational multicenter study aimed to evaluate the …
COVID-19 and the clinical course of rheumatic manifestations
The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
V Furer, C Rondaan, N Agmon-Levin, S Van Assen… - RMD open, 2021 - rmdopen.bmj.com
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis
Q Wang, J Liu, R Shao, X Han, C Su, W Lu - Rheumatology international, 2021 - Springer
Patients with rheumatic diseases are often more susceptible to different bacteria and viruses
because of immune impairment, but it is not clear whether there is a higher risk of infection …
because of immune impairment, but it is not clear whether there is a higher risk of infection …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
[HTML][HTML] Oral manifestations of COVID-19: Brief review
AM Paradowska-Stolarz - Dental and medical problems, 2021 - dmp.umw.edu.pl
The infection with a new type of virus–severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)–called coronavirus disease 2019 (COVID-19) was first described in …
(SARS-CoV-2)–called coronavirus disease 2019 (COVID-19) was first described in …
COVID-19 disease and dermatomyositis: a mini-review
J Qian, H Xu - Frontiers in immunology, 2022 - frontiersin.org
The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has
caused a large number of deaths, and there is still no effective treatment. COVID-19 can …
caused a large number of deaths, and there is still no effective treatment. COVID-19 can …